Purchase Order 75N91024P00208
Award Date
1/22/24
Potential Completion Date
3/17/24
Potential Value
$21K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Illumina, Inc. has been awarded a $124,564.88 firm fixed price delivery order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute for reagents and consumables. As the sole manufacturer of the sequencing instruments utilized by the agency, Illumina will provide proprietary supplies to support genomic sequencing and analysis at the agency's San Diego, California facility. No set-aside designation was applied to this order issued under an existing...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,381.70 firm fixed price purchase order to Illumina, Inc. for unspecified products or services. The place of performance will be in Bethesda, Maryland through September 2023. Illumina will deliver the requested items or work to support the National Cancer Institute, part of the NIH focused on cancer research, treatment, and initiatives to reduce the public health burden of cancer....
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency of the Department of Health and Human Services, to Illumina, Inc. for $79,576.32. The contract is for the delivery of biological kits, Illumina sequencing systems, and related services. It is a firm fixed-price delivery order with no set-aside designation. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has previously been awarded prime contracts and...
This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $12,081.90. The contract is not designated as a set-aside. Illumina, a manufacturer of genetic sequencing equipment and supplies, will provide goods and services to support genomic sequencing and analysis for research and diagnostics purposes. The award is likely part of a larger Indefinite...
This is a $17,508.94 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is not set aside for any special designation. Illumina has previously been awarded prime federal contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, consumables, and...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded Illumina, Inc. a $240,815.07 firm fixed price delivery order contract for the provision of reagents and consumables. The contract does not have a set-aside designation. Illumina is a for-profit manufacturer of sequencing and array-based genomic analysis solutions. Through prior prime federal contracts, Illumina has supplied a range of sequencing instruments, reagents, and...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Illumina, Inc. The $24,163.80 contract is for the provision of various Illumina sequencing systems, reagents, and related services. Illumina is a manufacturer of genetic and genomic analysis instrumentation and solutions. The contract does not have a set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from...
This is a $109,196.08 firm fixed price delivery order contract awarded to Illumina, Inc. by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The contract is for the provision of biological kits, with no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously held prime and subcontract awards with various government agencies, including NIH, CDC, USDA, and VA,...